Literature DB >> 3315262

Day-night patterns in bronchial patency and dyspnea: basis for once-daily and unequally divided twice-daily theophylline dosing schedules.

M H Smolensky1, G E D'Alonzo, G Kunkel, P J Barnes.   

Abstract

Asthma typically worsens overnight. Although 24-hr variation in environmental conditions may contribute to the worsening of dyspnea at night, this does not fully explain day-night patterns of this disease. Circadian (about 24-hr) rhythms in bioprocesses which influence airways patency constitute major contributory factors. The nighttime exacerbation of asthma may represent the influence of circadian bioperiodicities in bronchial patency, airways hyperreactivity to acetylcholine, histamine and house dust, and altered levels of several plasma constituents such as cortisol, epinephrine, histamine and cyclic AMP.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3315262     DOI: 10.3109/07420528709083521

Source DB:  PubMed          Journal:  Chronobiol Int        ISSN: 0742-0528            Impact factor:   2.877


  4 in total

Review 1.  Chronopharmacology and its application to the development of theophylline treatment schedules for asthma.

Authors:  K R Godfrey
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

2.  Development and evaluation of inhalational liposomal system of budesonide for better management of asthma.

Authors:  J J Parmar; D J Singh; Darshana D Hegde; A A Lohade; P S Soni; A Samad; Mala D Menon
Journal:  Indian J Pharm Sci       Date:  2010-07       Impact factor: 0.975

3.  Inhalational system for Etoposide liposomes: formulation development and in vitro deposition.

Authors:  J J Parmar; D J Singh; A A Lohade; Darshana D Hegde; P S Soni; A Samad; Mala D Menon
Journal:  Indian J Pharm Sci       Date:  2011-11       Impact factor: 0.975

4.  Formulation of inhalable lipid-based salbutamol sulfate microparticles by spray drying technique.

Authors:  Zahra Daman; Kambiz Gilani; Abdolhossein Rouholamini Najafabadi; Hamid Reza Eftekhari; Mohammad Ali Barghi
Journal:  Daru       Date:  2014-06-11       Impact factor: 3.117

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.